tlooto

Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates

Paula Hong, Stephan M. Koza, E. Bouvier

2012.1.1Journal of Liquid Chromatography & Related Technologies

Paper details

Journal
Journal of Liquid Chromatography & Related Technologies
Published
2012.1.1
Citations
530
References
134
Access
Open Access
Fields
Chemistry, Medicine

tlooto Summary

The history and background of SEC for the analysis of proteins and some of the applications of this mode of separation that are of particular importance to protein biopharmaceutical development are reviewed and some considerations in their implementation are highlighted.

Abstract

In recent years, the use and number of biotherapeutics has increased significantly. For these largely protein-based therapies, the quantitation of aggregates is of particular concern given their potential effect on efficacy and immunogenicity. This need has renewed interest in size-exclusion chromatography (SEC). In the following review we will outline the history and background of SEC for the analysis of proteins. We will also discuss the instrumentation for these analyses, including the use of different types of detectors. Method development for protein analysis by SEC will also be outlined, including the effect of mobile phase and column parameters (column length, pore size). We will also review some of the applications of this mode of separation that are of particular importance to protein biopharmaceutical development and highlight some considerations in their implementation.

Citation format

HONG, Paula; KOZA, Stephan M.; BOUVIER, E. Size-exclusion chromatography for the analysis of protein biotherapeutics and their aggregates. Journal of Liquid Chromatography & Related Technologies, 2012, 35(20): 2923–2950.